Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Equity: 2021-2025

Historic Return on Equity for Krystal Biotech (KRYS) over the last 4 years, with Sep 2025 value amounting to 0.18%.

  • Krystal Biotech's Return on Equity rose 12.00% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year increase of 12.00%. This contributed to the annual value of 0.10% for FY2024, which is 9.00% up from last year.
  • Krystal Biotech's Return on Equity amounted to 0.18% in Q3 2025, which was up 26.04% from 0.14% recorded in Q2 2025.
  • Krystal Biotech's 5-year Return on Equity high stood at 0.18% for Q3 2025, and its period low was -0.27% during Q1 2023.
  • Moreover, its 3-year median value for Return on Equity was 0.06% (2024), whereas its average is 0.02%.
  • Per our database at Business Quant, Krystal Biotech's Return on Equity declined by 12bps in 2022 and then surged by 40bps in 2024.
  • Over the past 5 years, Krystal Biotech's Return on Equity (Quarterly) stood at -0.14% in 2021, then decreased by 12bps to -0.26% in 2022, then climbed by 26bps to -0.00% in 2023, then climbed by 10bps to 0.10% in 2024, then climbed by 12bps to 0.18% in 2025.
  • Its last three reported values are 0.18% in Q3 2025, 0.14% for Q2 2025, and 0.13% during Q1 2025.